Literature DB >> 22009813

Cytomegalovirus co-infection in patients with human immunodeficiency virus in Iran.

Farhad Mehrkhani1, Sara Jam, Duman Sabzvari, Fatemeh Fattahi, Zahra Kourorian, SeyedAhmad SeyedAlinaghi, Hossain Jabbari, Minoo Mohraz.   

Abstract

Serum samples from 201 HIV positive patients were collected to determine the seroprevalence of CMV infection in Iranian HIV infected patients during March 2004 until March 2005 using conventional ELISA kits. An antibody level of >1.1 Iu/ml was considered positive. The seroprevalence of CMV infection was 94%.The maximum prevalence of CMV antibody was seen in patients with unsafe sex and IDUs. Prevalence of CMV was much higher in patients with low socioeconomic status and low level of education. 83% of patients with CD4<100 were CMV seropositive. Our study showed that a significantly high prevalence of CMV in HIV positive patients in Iran. By increasing the level of education and socioeconomic status the prevalence of CMV infection decreased.

Entities:  

Mesh:

Year:  2011        PMID: 22009813

Source DB:  PubMed          Journal:  Acta Med Iran        ISSN: 0044-6025


  3 in total

1.  Cytomegalovirus infection among Human Immunodeficiency Virus (HIV) infected individuals on highly active anti-retroviral therapy in North-Central Nigeria.

Authors:  Augustine Udeze; Mutiat Odebisi-Omokanye; Toluwani Ajileye
Journal:  Afr Health Sci       Date:  2018-12       Impact factor: 0.927

2.  CMV and EBV Co-Infection in HIV-Infected Children: Infection Rates and Analysis of Differential Expression of Cytokines in HIV Mono- and HIV-CMV-EBV Co-Infected Groups.

Authors:  Fizza Nazim; Hammad Afzal Kayani; Apsara Ali Nathwani; Fatima Mir; Syed Hani Abidi
Journal:  Viruses       Date:  2022-08-19       Impact factor: 5.818

3.  A survey of the frequency of cytomegalovirus-associated diarrhea in immunocompromised patients using a non-invasive method.

Authors:  Mahmoud Agholi; Akbar Safaei; Mani Ramzi; Gholam Reza Hatam; Jamal Sarvari
Journal:  Iran J Microbiol       Date:  2018-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.